Search research articles
Contact Us
Filters
Showing results (181-190 of 224) with videos related to
Page
of 23
Sort By:
Clinical Nuclear Medicine
|
May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphoma
O Israel, J Jerushalmi, S Ben-Haim, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models
E Dadachova, R A Bryan, A Frenkel, et al.
Biochimica Et Biophysica Acta
|
November 11, 1991
Developmental expression of glycogenolytic enzymes in rabbit tissues: possible relationship to fetal lung maturation
C B Newgard, B Norkiewicz, S D Hughes, et al.
Radiology
|
April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy
D Front, R Bar-Shalom, M Mor, et al.
Journal of Synchrotron Radiation
|
August 22, 2001
Extension of a tuned log spiral of revolution fluorescence XAFS detector, designed for optimal detection of a particular element Z, to XAFS of elements other than Z
D M Pease, M Daniel, J I Budnick, et al.
Cancer
|
May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumors
D Front, E Even-Sapir, O Israel, et al.
Radiology
|
October 1, 1987
Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake
D Front, O Israel, G Iosilevsky, et al.
Radiology
|
January 22, 2000
Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy
D Front, R Bar-Shalom, M Mor, et al.
Terapevticheskii Arkhiv
|
January 1, 1994
[The clinicoimmunological characteristics of blast transformation in lymphosarcomas]
N N Tupitsyn, G V Kruglova, D Sh Osmanov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1990
Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men
D Front, O Israel, G Iosilevsky, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 224) with videos related to
Sort By:
Page
of 23
Clinical Nuclear Medicine
|
May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphoma
O Israel, J Jerushalmi, S Ben-Haim, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models
E Dadachova, R A Bryan, A Frenkel, et al.
Biochimica Et Biophysica Acta
|
November 11, 1991
Developmental expression of glycogenolytic enzymes in rabbit tissues: possible relationship to fetal lung maturation
C B Newgard, B Norkiewicz, S D Hughes, et al.
Radiology
|
April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy
D Front, R Bar-Shalom, M Mor, et al.
Journal of Synchrotron Radiation
|
August 22, 2001
Extension of a tuned log spiral of revolution fluorescence XAFS detector, designed for optimal detection of a particular element Z, to XAFS of elements other than Z
D M Pease, M Daniel, J I Budnick, et al.
Cancer
|
May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumors
D Front, E Even-Sapir, O Israel, et al.
Radiology
|
October 1, 1987
Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake
D Front, O Israel, G Iosilevsky, et al.
Radiology
|
January 22, 2000
Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy
D Front, R Bar-Shalom, M Mor, et al.
Terapevticheskii Arkhiv
|
January 1, 1994
[The clinicoimmunological characteristics of blast transformation in lymphosarcomas]
N N Tupitsyn, G V Kruglova, D Sh Osmanov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1990
Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men
D Front, O Israel, G Iosilevsky, et al.
Page
of 23